TY - JOUR
T1 - The PMP22 gene and its related diseases.
AU - Li, Jun
AU - Parker, Brett
AU - Martyn, Colin
AU - Natarajan, Chandramohan
AU - Guo, Jiasong
N1 - Funding Information:
This work is, in part, supported by NIH (R01NS066927) and Veterans Affair (BLR&D).
PY - 2013/4
Y1 - 2013/4
N2 - Peripheral myelin protein-22 (PMP22) is primarily expressed in the compact myelin of the peripheral nervous system. Levels of PMP22 have to be tightly regulated since alterations of PMP22 levels by mutations of the PMP22 gene are responsible for >50 % of all patients with inherited peripheral neuropathies, including Charcot-Marie-Tooth type-1A (CMT1A) with trisomy of PMP22, hereditary neuropathy with liability to pressure palsies (HNPP) with heterozygous deletion of PMP22, and CMT1E with point mutations of PMP22. While overexpression and point-mutations of the PMP22 gene may produce gain-of-function phenotypes, deletion of PMP22 results in a loss-of-function phenotype that reveals the normal physiological functions of the PMP22 protein. In this article, we will review the basic genetics, biochemistry and molecular structure of PMP22, followed by discussion of the current understanding of pathogenic mechanisms involving in the inherited neuropathies with mutations in PMP22 gene.
AB - Peripheral myelin protein-22 (PMP22) is primarily expressed in the compact myelin of the peripheral nervous system. Levels of PMP22 have to be tightly regulated since alterations of PMP22 levels by mutations of the PMP22 gene are responsible for >50 % of all patients with inherited peripheral neuropathies, including Charcot-Marie-Tooth type-1A (CMT1A) with trisomy of PMP22, hereditary neuropathy with liability to pressure palsies (HNPP) with heterozygous deletion of PMP22, and CMT1E with point mutations of PMP22. While overexpression and point-mutations of the PMP22 gene may produce gain-of-function phenotypes, deletion of PMP22 results in a loss-of-function phenotype that reveals the normal physiological functions of the PMP22 protein. In this article, we will review the basic genetics, biochemistry and molecular structure of PMP22, followed by discussion of the current understanding of pathogenic mechanisms involving in the inherited neuropathies with mutations in PMP22 gene.
UR - http://www.scopus.com/inward/record.url?scp=84883137706&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84883137706&partnerID=8YFLogxK
U2 - 10.1007/s12035-012-8370-x
DO - 10.1007/s12035-012-8370-x
M3 - Review article
C2 - 23224996
AN - SCOPUS:84883137706
SN - 0893-7648
VL - 47
SP - 673
EP - 698
JO - Molecular Neurobiology
JF - Molecular Neurobiology
IS - 2
ER -